Top Suppliers:I want be here

2719-05-3

2719-05-3 structure
2719-05-3 structure
  • Name: 4,4'-diacetamidodiphenylmethane
  • Chemical Name: 4,4'-diacetamidodiphenylmethane
  • CAS Number: 2719-05-3
  • Molecular Formula: C17H18N2O2
  • Molecular Weight: 282.337
  • Catalog: Research Areas Others
  • Create Date: 2018-02-20 08:00:00
  • Modify Date: 2024-01-03 17:02:13
  • FH1(BRDK4477) is a small molecule that can enhance the functions of cultured hepatocytes.IC50 value:Target: In vitro: FH1(BRD-K4477) enhances hepatocyte functions, and promotes the maturation of well-differentiated cultures of iHeps, which potentially alleviates a major obstacle to the use of iPS cells as a renewable source of functional human hepatocytes.

Name 4,4'-diacetamidodiphenylmethane
Synonyms N,N'-AcetylMDA
4.4'-Bis-acetamino-diphenylmethan
N,N'-diacetyl-4,4'-methylenedianiline
4,4'-diacetoamino-diphenylmethane
N,N'-(Methylenedi-4,1-phenylene)diacetamide
4',4''-METHYLENEBIS(ACETANILIDE)
N1-{4-[4-(acetylamino)benzyl]phenyl}acetamide
4,4'-Diacetyldiaminodiphenylmethan
Acetamide, N,N'-(methylenedi-4,1-phenylene)bis-
N-[4-[(4-Acetamidophenyl)Methyl]Phenyl]Acetamide
BRD-K4477
FH1
Description FH1(BRDK4477) is a small molecule that can enhance the functions of cultured hepatocytes.IC50 value:Target: In vitro: FH1(BRD-K4477) enhances hepatocyte functions, and promotes the maturation of well-differentiated cultures of iHeps, which potentially alleviates a major obstacle to the use of iPS cells as a renewable source of functional human hepatocytes.
Related Catalog
References

[1]. Shan J, et al. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol. 2013 Aug;9(8):514-20.

Density 1.2±0.1 g/cm3
Boiling Point 564.6±43.0 °C at 760 mmHg
Molecular Formula C17H18N2O2
Molecular Weight 282.337
Flash Point 217.8±28.3 °C
Exact Mass 282.136841
PSA 58.20000
LogP 1.93
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.635
Storage condition -20℃
Symbol GHS09
GHS09
Signal Word Warning
Hazard Statements H400
Precautionary Statements P273
Risk Phrases R22;R40
Safety Phrases S22-S36/37
RIDADR UN 3077 9 / PGIII

~84%

2719-05-3 structure

2719-05-3

Literature: Kimura, Tsutomu; Hosokawa-Muto, Junji; Kamatari, Yuji O.; Kuwata, Kazuo Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 5 p. 1502 - 1507

~86%

2719-05-3 structure

2719-05-3

Literature: Barbero, Margherita; Bazzi, Stefano; Cadamuro, Silvano; Dughera, Stefano; Ghigo, Giovanni European Journal of Organic Chemistry, 2009 , # 25 p. 4346 - 4351

~%

2719-05-3 structure

2719-05-3

Literature: Journal of the American Chemical Society, , vol. 68, p. 2600 Journal of the American Chemical Society, , vol. 3, p. 1502,1503

~59%

2719-05-3 structure

2719-05-3

Literature: Mashraqui, Sabir H.; Nirantar, Swati S.; Biswas, Maloyesh M. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1995 , vol. 34, # 12 p. 1102 - 1104

~%

2719-05-3 structure

2719-05-3

Literature: Helvetica Chimica Acta, , vol. 12, p. 868 Journal of the American Chemical Society, , vol. 47, p. 2615

~%

2719-05-3 structure

2719-05-3

Literature: Helvetica Chimica Acta, , vol. 12, p. 868

~%

2719-05-3 structure

2719-05-3

Literature: Journal of the Chemical Society, , p. 1886,1892

~%

2719-05-3 structure

2719-05-3

Literature: Justus Liebigs Annalen der Chemie, , vol. 283, p. 161 Chemische Berichte, , vol. 25, p. 304

~%

2719-05-3 structure

2719-05-3

Detail
Literature: Journal of the Chemical Society, , p. 1886,1892